GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals
GSK Plc (NYSE: GSK ) stock rose Tuesday after the British drugmaker reported better-than-expected second-quarter results. Launches $2.52 Billion Cost-Savings Program GSK said its new Accelerate Growth program targets 1.9 billion pounds ($2.52 billion) in annual savings by 2029, with expected implementation costs of 2.4